Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Yankees Acquire J.D. Davis

By | at

The Yankees announced this afternoon that they’ve acquired infielder J.D. Davis and cash considerations from the A’s in exchange infielder Jordan Groshans. Davis had been designated for assignment by the A’s earlier this week. The Yankees transferred right-hander Nick Burdi to the 60-day injured list in order to make room for Davis on the 40-man roster.

Davis, 31, signed with the A’s in late spring after the Giants released Davis during Spring Training in order to get out from under most of the $6.9MM salary he had been awarded in arbitration over the winter. He managed to secure a guarantee of just $2.5MM from Oakland, a far cry from his previously-awarded arbitration salary even after factoring in the roughly $1.1MM in termination pay he received from San Francisco.

After that late spring controversy, Davis went on to appear in 39 games with the A’s where he slashed a roughly league-average .236/.304/.366 in 135 trips to the plate while splitting time between first base, third base, and DH. While his offensive numbers this year leave something to be desired, Davis’s positional versatility and track record as an above-average hitter make him a perfect fit for the Yankees’ current needs.

The club lost starting DH Giancarlo Stanton to the injured list earlier today, and first baseman Anthony Rizzo was also placed on the shelf not long ago due to a fractured forearm. Rookie Ben Rice has scuffled a bit in his first few games replacing Rizzo at first base, while the club has no obvious alternative to Stanton as an everyday DH in-house. Even at third base, where the club is currently relying on the combination of Oswaldo Cabrera and DJ LeMahieu, New York has gotten a wRC+ of just 78 — this ranks second-worst of all AL third-base units, ahead of only the White Sox.

Enter Davis, who entered the 2024 season with five consecutive seasons of solid production with the Mets and Giants. Since the start of the 2019 season, Davis has slashed a solid .265/.349/.438 with a wRC+ of 118. While he’s struck out a 27.1% clip during that time, he’s walked at a healthy 10% rate while flashing 20-homer power. That sort of production would be a major upgrade for a Yankees club that has generally struggled to produce offense outside of the outfield this year even before losing Stanton for at least the short-term. Davis seems likely to slide into the everyday DH role for the Yankees while Stanton is unavailable, but could also spell Rice at first base against left-handed pitching and even contribute at third alongside LeMahieu and Cabrera.

On days where Davis is playing the infield, the Yankees could offer Aaron Judge or Juan Soto the opportunity to get a half-day of rest as a DH and improve the club’s outfield defense by inserting glove-first center fielder Trent Grisham into the mix. When Stanton eventually returns to reclaim regular DH, the Yankees could pick and choose from Davis, Rice, Cabrera, and LeMahieu based on how everyone is performingt. That being said, if Davis can even maintain his production as an Athletic in the Bronx he should be a shoe-in for at least semi-regular playing time around the Yankees infield even after Stanton’s eventual return.

In exchange for Davis’ services, the Yankees are sending Groshans to Oakland. The 24-year-old’s stint in the Yankees organization was a relatively brief one, as the club claimed him off waivers from the Marlins back in February. He was outrighted off their 40-man roster in early March and has struggled to this point in the 2024 season with a .232/.310/.281 slash line while playing all four infield spots in 50 games split between the Double- and Triple-A levels. That follows a similarly rough performance at Triple-A with Miami last year; in 528 plate appearances across 125 games in 2023, Groshans slashed a paltry .244/.339/.330 with just six home runs.

Despite Groshans’ struggles over the past two seasons, it’s not hard to see why the A’s would be willing to give the youngster a shot. After all, the infielder was the 12th overall pick in the 2018 draft by the Blue Jays and received plenty of top prospect buzz earlier in his career, including a stint as a consensus top-50 prospect in the sport back in 2021. That pedigree combined with Groshans’ stronger numbers at the Double-A level earlier in his career provide some reason for optimism that he could contribute at the big league level at some point.

That possibility is surely an attractive one for an Oakland club that has struggled to find a consistent option at third base this year while cycling between Davis, Abraham Toro, and Tyler Nevin at the position. Toro will be out until at least the All-Star break recovering from a hamstring strain, leaving even more opportunity for Groshans to win some playing time at the hot corner.

Cardinals Notes: Arenado, Siani, Contreras, Nootbaar

By | at

TODAY: Arenado received a pain-killing injection in his forearm today, Marmol told John Denton and other reporters today.  It isn’t yet clear if Arenado will need an IL stint, but he wasn’t available for pinch-hitting duties in today’s game.

JUNE 22: Cardinals star Nolan Arenado departed the club’s win over the Giants in the eighth inning today due to discomfort in his left forearm, as noted by MLB.com’s John Denton. Notably, that’s not the same arm that Arenado suffered an elbow contusion on after being struck by a pitch from Marlins right-hander Huascar Brazoban earlier this week. More information was not made available following tonight’s game beyond the fact that Arenado would be evaluated further tomorrow.

It’s an unfortunate turn of events in the midst of what has been a difficult season for the 33-year-old veteran, who is slashing just .260/.315/.375 with a 99 wRC+. That would be Arenado’s first below-average offensive performance in a 162-game season since his rookie campaign back in 2013. He’s paired that lackluster offense with surprisingly pedestrian glovework at third base, where he’s been worth +0 Outs Above Average and -5 Defensive Runs Saved. That’s a far cry from the fielding he offered at the position earlier in his career, when he won the NL Gold Glove award at third base in ten consecutive seasons from 2013 to 2022.

Even with that diminished production this year, however, the loss of Arenado would still be a tough blow for the Cardinals should he end up missing time due to his injury. Not only is he just two seasons removed from a campaign where he was a finalist for the NL MVP award, but the eight-time All Star is the club’s only clear solution at third base given the present construction of the lineup. While former top prospect Jordan Walker came up as a third baseman and is currently in the minors, the 22-year-old has struggled both in Triple-A and at the big league level this year and converted to the outfield full time last year making him an unlikely choice to take over for Arenado in the case of an injury.

Super-utility bat Brendan Donovan has played the hot corner at times, but he’s settled in as the club’s regular left fielder in the absence of Lars Nootbaar. It’s possible that Donovan could slide over to third base and open up left field for Dylan Carlson, but perhaps a more likely scenario would see the Cardinals rely more heavily on bench bats Brandon Crawford and Jose Fermin to fill in for Arenado at third. That’s especially true given the fact that center fielder Michael Siani also exited today’s game due to an injury, though Jeff Jones of the Belleville News-Democrat relayed after the game that x-rays on Siani’s ribs after he hit the ground hard on a diving play in the outfield came back negative. The 24-year-old appears to have avoided a major injury, but even a day-to-day issue would at least temporarily weaken the club’s outfield depth noticeably.

As for Nootbaar, the 26-year-old has been sidelined by an oblique strain since the end of May. Jones relays that he appears to be making progress in his rehab but the outfielder has not yet even begun to take batting practice, instead only hitting off a tee at this stage in the process. That would seem to indicate that Nootbaar, who will surely require a rehab assignment before he can return to action, isn’t going to be returning to the club’s positional mix any time soon to provide Marmol additional flexibility as he fills out the club’s lineup card in the wake of Arenado’s and Siani’s possible injuries.

One piece of good news for Cardinals fans is the impending return of star catcher Willson Contreras, who Marmol told reporters (including Jones) will catch seven innings for Triple-A Memphis tonight before DH’ing tomorrow’s game. As Jones notes, Contreras caught for the Redbirds yesterday and Marmol acknowledged that seeing how the 32-year-old held up after catching back to back games was the last major box the club needed to check regarding Contreras’s rehab.

Contreras has been out since early May with a broken forearm and was initially expected to miss ten weeks due to the injury, but the backstop has long since clearly been ahead of that schedule and seems like he could factor into the club’s plans before the end of the month. The slugger posted an excellent .280/.398/.551 slash line in 31 games for the Cardinals this year before being sidelined by the injury and could provide a boost to an offense that has posted a collective wRC+ of just 95 to this point in the season.

A’s Select Aaron Brooks

By | at

4:02PM: Jimenez has a Grade 2 oblique strain and is expected to miss 6-8 weeks, MLB.com’s Martin Gallegos writes (X link).

11:51AM: The A’s announced this morning that they’ve selected the contract of right-hander Aaron Brooks. Brooks will take the place of righty Dany Jimenez on the active roster, who the club placed on the 15-day injured list with a left oblique strain.

Brooks, 34, signed with the A’s on a minor league deal over the winter and was called up last month to help fill out the club’s rotation mix amid a number of injuries to key veterans such as Alex Wood, Ross Stripling, and Paul Blackburn. That first stint in the majors saw the righty post a 5.82 ERA with a 5.59 FIP in 21 2/3 innings of work across four starts with a strikeout rate of just 10% against a 6% walk rate. Brooks found himself DFA’d earlier this month when right-hander Luis Medina was activated from the 60-day IL, but remained with the club after being assigned outright to Triple-A and will now get another opportunity in the majors, albeit this time in a long relief role.

Despite his lackluster results earlier this year, it’s at least feasible to imagine the righty showing off a stronger performance in his second stint in the big leagues this season. After all, he’s a veteran of six major league seasons who has compiled 56 appearances and 32 starts in the majors during that time as a back-end starter and long reliever who enjoyed some success overseas while pitching in the Korea Baseball Organization from 2020-21. He’s also posted a solid 4.30 ERA in 52 1/3 innings of work at the Triple-A level this year despite the inflated offensive environment of the Pacific Coast League.

Brooks will take the roster spot of Jimenez, who has been a decent middle reliever this season for the club this season. In 23 2/3 innings of work, Jimenez has pitched to a solid 3.04 ERA with a decent 20% strikeout rate. Those solid results have come in spite of extreme wildness, however. The right-hander has walked an eye-popping 17.1% of batters faced this year, a trend consistent with the righty’s career numbers. Since making his A’s debut back in 2022, Jimenez has posted a solid 3.32 ERA (118 ERA+) but has never posted a walk rate below 12.4% in a season, while walking 14.5% of batters faced overall while in an Oakland uniform.

Now sidelined for the foreseeable future with an oblique strain, Jimenez figures to work his way back into the big league relief mix once healthy. With pieces like Lucas Erceg, T.J. McFarland, and Austin Adams likely to attract interest from clubs in need of bullpen help this summer, it’s possible that the A’s will have plenty of room for Jimenez if he returns following the trade deadline even in the likely event that the club holds onto superstar closer Mason Miller.

Yankees Place Giancarlo Stanton On 10-Day Injured List

By | at

3:26PM: Stanton confirmed to Hoch and other reporters that he did get a PRP shot today, and estimated that he’ll spend about four weeks on the IL.

3:10PM: Stanton might receive a PRP injection but the strain is considered “mild,” Boone told MLB.com’s Bryan Hoch and other reporters.  The Yankees don’t yet have a timeline on when Stanton might return to action.

9:42AM: The Yankees announced this morning that they’ve placed slugger Giancarlo Stanton on the 10-day injured list. Infielder Oswald Peraza was recalled to the big league roster in the corresponding move, as first reported by El Extrabase’s Daniel Alvarez-Montes last night.

Stanton, 34, departed yesterday’s game against the Braves in the top of the sixth inning after feeling tightness in his left hamstring while running the bases earlier in the game. Manager Aaron Boone indicated to reporters (including The Athletic’s Brandon Kuty) after the game that Stanton was scheduled to undergo tests today to determine the severity of the issue but noted that Stanton was in “good spirits” and that the club was hopeful the issue wasn’t too serious. The results of Stanton’s testing today are not yet known, although the club evidently believes that he’ll need to miss at least the next ten days before he can return to action. Being cautious with Stanton, who has a long history of lower half injuries throughout his career, is understandable given the risk of aggravating the hamstring further if he were to attempt to play through the injury.

Even so, it’s a frustrating turn of events for both Stanton and the Yankees given the veteran’s resurgence at the plate to this point in the season. Long one of the game’s most feared sluggers, Stanton posted relatively pedestrian numbers over the past two seasons, slashing just .202/.286/.442. That production was only good for a 103 wRC+ that’s essentially league average, and not particularly close to the value the Yankees were surely hoping to get from a full-time DH who they pay an average of $25MM to annually. The veteran’s production in 69 games this season has been far closer to what the Yankees are surely hoping for from him, as he’s impressed with a .246/.302/.492 slash line (126 wRC+) while crushing 18 home runs in just 281 trips to the plate.

New York will have to go without that strong production in the middle of their lineup for at least the foreseeable future, delivering another blow to an offense that has generally struggled to produce outside of star sluggers Juan Soto and Aaron Judge. Stanton shelved, it’s possible the Yankees could look to improve their outfield defense by placing Trent Grisham in center field, kicking Judge back over to his native right field while allowing Soto to move into a DH role. Grisham has struggled to a wRC+ of just 71 at the plate this year, though his quality work with the glove could still make him a more attractive option than more frequently relying on Oswaldo Cabrera (78 wRC+) or DJ LeMahieu (51 wRC+) outside of their current role splitting time at third base.

Taking Stanton’s place on the roster is Peraza, who has been sidelined for almost the entire season to this point due to a shoulder strain. In 28 games at the Triple-A level since returning from injury, Peraza has struggled to a .178/.313/.215 slash line that suggests he’s unlikely to be the solution for replacing Stanton’s production offensively, although the former consensus top-50 prospect would likely be the club’s best defensive option at third base and could free LeMahieu and Cabrera up for more frequent appearances at DH or first base, where youngster Ben Rice has been getting his first taste of big league action while Anthony Rizzo recovers from a fractured forearm.

Blue Jays Claim Jose Cuas Off Waivers From Cubs

By | at

The Cubs announced this afternoon that right-hander Jose Cuas has been claimed off waivers by the Blue Jays. Cuas was designated for assignment earlier this week in order to make room for righty Ethan Roberts on the club’s 40-man roster. The move puts Toronto’s 40-man roster at capacity.

Cuas, who will celebrate his 30th birthday later this week, made his big league debut with the Royals back in 2022 but was traded to the Cubs in exchange for outfielder Nelson Velazquez at the trade deadline last summer. He was a decent middle reliever for the Royals during his time in Kansas City, pitching to a 4.08 ERA (106 ERA+) with a 4.41 FIP in 79 1/3 innings of work for the club between the 2022 and ’23 campaigns. Unfortunately for both Cuas and the Cubs, the wheels began to come off for the sidearming righty upon his arrival in Chicago last year.

While his 3.04 ERA in 27 appearances for the Cubs down the stretch last summer was actually fairly strong, it came with concerning peripherals. His strikeout rate dipped from a strong 27.1% during his time with the Royals last year to a worrisome 19% in Chicago, while his walk rate simultaneously ballooned from a manageable 10% figure in Kansas City all the way up to 14% for the north siders. While a strong 55.6% groundball rate allowed Cuas to keep the damage to a minimum, he was no longer looking the part of a quality middle relief option.

Things took an even worse turn for Cuas in 2024 when his groundball rate plummeted to just 31%. While his walk rate dropped down to a career-best 9.2% figure, that came at least in part as a result of opposing hitters teeing off Cuas pitches with a 14.3% barrel rate and a 45.2% Hard Hit rate. While Cuas’s strikeout rate crept back up to a more acceptable 21.5% this year, that still wasn’t enough to stop the right-hander from surrendering 12 runs (11 earned) in 13 1/3 innings of work for the Cubs this year, leaving him with a 7.43 ERA and a 5.99 FIP.

Despite those deep struggles during his time in Chicago, it’s not hard to see why the Blue Jays would want to take a chance on the righty. After all, when Cuas’s arsenal is working well, his sinker/slider combo allows him to strike out around a quarter of the batters he faces while keeping walks to a clip of around 10% and eliciting grounders on around half of his batted balls. That’s certainly the profile of a valuable pitcher, even though Cuas has not been able to put it all together at the big league level yet during his career.

Even if he isn’t able to reach that potential, the right-hander still provides the Blue Jays with an optionable relief arm on a minimum salary who can be shuttled from Triple-A to the majors as necessary. That’s a valuable commodity for any bullpen, but especially for a Blue Jays bullpen that has posted a league-worst 4.83 FIP to this point in the 2024 campaign. Should the club turn to Cuas at some point, he’d likely factor into the middle relief mix alongside the likes of Zach Pop and Genesis Cabrera.

Marlins Place Braxton Garrett On 15-Day Injured List With Forearm Flexor Strain

By | at

The Marlins announced several roster moves this morning, headlined by the club placing left-hander Braxton Garrett on the 15-Day injured list with a left forearm flexor strain. The club also optioned right-hander Shaun Anderson to Triple-A. Taking Garrett and Anderson’s spots on the club’s active roster will be right-hander Kyle Tyler and left-hander Kent Emanuel, both of whom had their contracts selected. Left-hander Jesus Luzardo and right-hander Edward Cabrera were both transferred to the 60-day injured list to clear space for the duo on the 40-man roster.

Garrett’s placement on the injured list isn’t necessarily a surprise, as the club had already scratched him from today’s start due to elbow soreness yesterday. With that being said, the diagnosis of a forearm flexor strain is a concerning one that suggests Garrett could be in for a lengthy absence, though details about his exact timeline are not yet available. For Marlins fans, it surely brings to mind September of last year, when the Marlins provided the same diagnosis for right-hander Sandy Alcantara before the ace ultimately required Tommy John surgery.

Fortunately, not all forearm strains require such drastic treatment. Nationals right-hander Josiah Gray suffered a similarly-termed strain back in April that ultimately proved to be purely muscular without damage to the UCL. Gray is currently on a rehab assignment and could factor into the Nationals’ pitching plans prior to the All Star break, roughly three months after the initial injury. A similar timeline could see Cabrera return sometime in September, prior to the end of the 2024 campaign.

Regardless of when Cabrera winds up being able to return to the club, however, the Marlins figure to be in a bit of a pickle as they look to piece together their rotation mix. Miami currently has seven starters on the injured list, leaving them with lefty Trevor Rogers, righty Roddery Munoz, and righty Yonny Chirinos as their only three established starting pitchers. That trio will be joined by Tyler, who is slated to start today’s game against the Mariners. A 20th-round pick by the Angels in the 2018 draft, the righty has made eight multi-inning relief appearances in the big leagues since he first made his MLB debut back in 2021, though he’s never started a game at the big league level.

He’s pitched fairly well in his limited opportunities in the majors with a 2.45 ERA and 4.36 FIP in 18 1/3 innings of work. That includes a single appearance with the Marlins earlier this year where he allowed one run in two frames where he allowed one hit and no walks with one strikeout. It’s unclear if Tyler will continue to pitch as part of the club’s rotation after today or if this is a spot start for the 27-year-old. Also joining Tyler on the active roster is the lefty Emanuel, who has been shuttling between the 40-man roster and the minor leagues all throughout the 2024 campaign for the Marlins. In 8 1/3 innings of work for the club this year across four appearances, Emanuel has struggled to a 7.56 ERA with an 8.19 FIP. Nonetheless, the southpaw will provide the club with a multi-inning option out of the bullpen who could piggyback with the right-handed Tyler if necessary this afternoon.

As for Luzardo and Cabrerea, the 60-day IL placements come as a mild surprise for both players. In Luzardo’s case, the lefty was placed on the IL just yesterday with a lumbar stress reaction, and manager Skip Schumaker suggested that injury typically has a 4-6 week timeline. Now that Luzardo is out for at least the next two months, it’s safe to say the Marlins believe he’ll be out for longer than that general timeline. He’ll first be eligible to return from the shelf in late August. Cabrera’s placement also somewhat surprising given the fact that he’s already built up to the 50-pitch range on a rehab assignment, though given the fact that the righty would be eligible to be activated from the shelf in just two weeks it could be a purely procedural transaction.

Orelvis Martinez Receives 80-Game Suspension Following Positive PED Test

By | at

The MLB commissioner’s office announced this morning that Blue Jays infielder Orelvis Martinez has received an 80-game suspension without pay after testing positive for Clomiphene, a banned performance enhancing substance. The suspension is effective immediately. Martinez has since been placed on the restricted list, and the Blue Jays have selected the contract of outfielder Steward Berroa to replace the infielder on the active and 40-man rosters.

“The Blue Jays fully support Major League Baseball’s Joint Drug Prevention and Treatment Program, and strongly believe in keeping the game on a level playing field,” Blue Jays GM Ross Atkins said in a statement this morning. “We were both surprised and disappointed to hear of Orelvis Martinez’s suspension. We will do everything in our power to ensure Orelvis has learned from this mistake. Orelvis has our support, and we know he will get through this.”

Martinez released a statement of his own via the MLB Players Association:

“For the past two years, I have been trying to start a family with my girlfriend. During the offseason, we visited a fertility clinic in the Dominican Republic and after getting lab work done, we were prescribed a treatment, which included a medication called Rejun 50. Unfortunately, Rejun 50 contains a banned substance called Clomiphene.

We wanted to keep this matter private, even within our family, and trusted the doctor who assured us this treatment did not include performance enhancing drugs. Therefore, I made the mistake of not disclosing this to my team or the MLBPA. With that said, I took full responsibility for my actions and accepted my suspension.

I want to apologize to my teammates in both Buffalo and Toronto, the Blue Jays organization, and most importantly, the fans who have supported me during my career. I will learn from this experience and come back to the field in September.”

The news is a major blow to the Blue Jays, who recalled Martinez for his big league debut just this past week to join the club’s infield mix after shortstop Bo Bichette hit the injured list with a calf strain. Martinez has just one game under his belt in the majors so far, having gone 1-for-3 with a strikeout while playing second base in his big league debut on Friday. While Martinez’s big league career had only just begun, he’s long been considered a consensus top-100 prospect in the sport and was in the midst of an excellent showing at Triple-A this year when he received the call to the majors. In 63 games for the club’s Buffalo affiliate this year, Martinez slashed .260/.343/.523 while playing both second and third base.

Now, Martinez’s big league career is on hold just days after it first began. The earliest he’ll be able to return to play in the big leagues is September 23 against the Red Sox, although given the fact that Martinez would be ineligible to participate in the postseason due to his suspension and that date landing just six games before the end of the regular season, it wouldn’t be a surprise if Martinez did not end up returning to the majors until the 2025 campaign.

Fortunately for the Blue Jays, the club has plenty of options at its disposal to fill out the club’s infield mix while Bichette is injured, even without Martinez. Isiah Kiner-Falefa has stepped into the everyday role at shortstop since Bichette hit the shelf last week, and the club figures to mix and match between Davis Schneider, Ernie Clement, Addison Barger, and Spencer Horwitz at second and third base while Bichette is away. The addition of Berroa to the roster mix should allow Schneider to mix into the infield more frequently than he has in recent weeks, as he’s split time between the keystone and left field to this point in the season.

As for Berroa, the 25-year-old made his pro debut with the Jays back in 2017 and has worked his way through the club’s minor league system since then, ultimately reaching Triple-A late last year. He struggled in that initial cup of coffee but has hit fairly well in 62 games at the highest level of the minors this season with a .295/.380/.451 slash line across 222 trips to the plate. Berroa figures to factor into the club’s outfield mix behind regulars Daulton Varsho, Kevin Kiermaier, and George Springer alongside Schneider.

Phillies Place Taijuan Walker On 15-Day Injured List

By | at

The Phillies announced this morning that they’ve placed right-hander Taijuan Walker on the 15-day injured list due to inflammation in his right index finger. Right-hander Michael Mercado was recalled to the majors in a corresponding move. Mercado’s first appearance will be his big league debut.

Walker, 32 in August, has had a difficult 2024 season as he’s dealt with both injuries and ineffectiveness. A shoulder impingement delayed his season debut until the tail end of April, and he’s struggled considerably in ten starts since then. The righty sports a 5.60 ERA and 5.77 FIP overall on the season, figures that are 37% and 40% worse than the league average respectively. Just two of Walker’s ten appearances have been quality starts, and opponents have batted an eye-popping .278/.353/.511 against him in seven starts dating back to May 16. In other words, Walker’s opponents have teed off in recent weeks to achieve results roughly comparable to those Guardians star Jose Ramirez (.271/.330/.528) has posted this season.

Walker’s struggles came to a head Friday night against the Diamondbacks, when the righty allowed four runs on five hits and three walks across just four innings of work while striking out only three batters. Manager Rob Thomson told reporters (as noted by MLB.com’s Injury Tracker) yesterday that Walker was dealing with a “hot spot” on his finger and suggested that the issue has “been probably going on for a while.” Specifically, Thomson suggested that the injury may have impacted the efficacy of Walker’s splitter. The splitter was Walker’s most commonly used pitch last year, when he threw it 33.2% of the time according to Statcast. That usage has dropped to just 17.4% in 2024, and MLB.com notes that he’s thrown the pitch just sixteen times total over his past two starts.

That drop in usage has corresponded with a drop in efficacy. 2023 saw opposing hitters hit just .205 against Walker’s splitter, with a .295 slugging percentage and a .257 wOBA. Those strong results are a far cry for what the right-hander has produced with the pitch this year, as opponents have hit a whopping .426 with a .704 slugging percentage and a wOBA of .477. That .426 figure is the highest average allowed by Walker on any pitch this year, in sharp contrast to last year where his splitter boasted a lower average against than any pitch in his repertoire except for his rarely-used sweeper.

Given the fact that Walker’s finger issue has seemingly impacted his ability to throw his most important pitch, it’s hardly a surprise that the right-hander has suffered such extreme difficulties to this point in the season. Going forward, the Phillies will sit the righty down for at least the next two weeks in order to give the inflammation time to settle down. It’s surely a fairly easy decision for Philadelphia to not have Walker continue to try and play through the issue given the presence of right-hander Spencer Turnbull. Turnbull has been excellent for the club this year while swinging between the rotation and the bullpen, with a 2.63 ERA and 3.57 FIP in 51 1/3 innings across 16 appearances (six starts).

While Turnbull has not started a game since late April, the righty threw 49 pitches in his most recent outing on Friday and figures to be able to step into the rotation and offer the Phillies solid production in Walker’s stead. That leaves the long relief role out of the bullpen to Mercado, who is set to replace Walker on the club’s roster. Mercado was the Rays’ second-round pick in the 2017 draft but did not make an appearance at the big league level with the club before being traded to the Phillies back in November. Philadelphia swiftly placed Mercado on their 40-man roster and sent him to Triple-A to open the season, where he’s excelled with a 1.71 ERA and a 22.8% strikeout rate in 47 1/3 innings of work split between the rotation and bullpen at the level.

Dave Dombrowski Discusses Cristopher Sanchez Extension, Ranger Suarez’s Future

By | at

When the Phillies announced a four-year extension with young left-hander Cristopher Sanchez yesterday, president of baseball operations Dave Dombrowski revealed to reporters (including Matt Gelb of The Athletic) that the deal isn’t one they would have considered making if Sanchez and his agent, Gene Mato, hadn’t approached him about the possibility of a long-term deal. Even at that point, Dombrowski noted that he had some reservations about negotiating in-season.

“As much as we’d love to have him, during the middle of the season, it’s not normally something that I would like to get into,” Dombrowski said, as relayed by Gelb. “Because it can be a distraction for the player.”

Fortunately, the extension talks didn’t take very long as Gelb notes that it took just one week of negotiations before the sides settled on the four-year, $22.5MM guarantee with two club options that could extend the club’s window of control over Sanchez through the end of the 2030 campaign. The smooth negotiations between Dombrowski and Sanchez’s camp appear to have been crucial in pushing the deal across the finish line given the Phillies’ stated concerns that a protracted negotiation process could become a distraction from the season at hand.

That apparent trepidation with regards to in-season extensions could serve as a clue for how the Phillies will approach left-hander Ranger Suarez, who Gelb notes the Phillies have interest in extending. Suarez is currently slated to hit free agency following the 2025 season, but Gelb notes that talks have yet to progress between the sides and appear likely to wait until after the 2024 campaign has concluded. For his part, Dombrowski noted that the club “love[s]” Suarez and that they “hope that he’s part of the organization for a long time,” but also declined to discuss the state of negotiations with the lefty.

If the Phillies want to extend Suarez, it’s sure to come with a much heftier price tag than the Sanchez extension. Sanchez’s deal is more or less in line with the low end of what pitchers in his service time bracket have received in extensions, just ahead of the $18.8MM guarantee the Red Sox gave to right-hander Garrett Whitlock but a far cry from the $50M+ guarantees afforded to Boston’s Brayan Bello and Cincinnati’s Hunter Greene. Suarez, who will be just one year from free agency this offseason, is in a completely different realm of contract expectations.

The two hurlers to sign extensions with just one year to go before free agency in recent memory are Mariners right-hander Luis Castillo and Blue Jays right-hander Jose Berrios, both of whom did so shortly after being dealt to new teams the previous summer. Castillo signed a $108MM guarantee over five years with Seattle, while Berrios signed in Toronto on a seven-year deal that guaranteed him $131MM. Both hurlers had a much longer track record of success in the starting rotation at the time of their extensions than Suarez, who didn’t become a full-time starting pitcher until the 2022 season.

On the other hand, however, Suarez has undeniably been more dominant than either hurler in the years leading up to the start of extension negotiations. The lefty has pitched to a 2.91 ERA (142 ERA+) with a 3.39 FIP in 478 2/3 innings of work since the start of the 2021 season. That eclipses the work of both Berrios (118 ERA+, 3.78 FIP) and Castillo (132 ERA+, 3.43 FIP) on a rate basis in their final four years before signing, though both Castillo and Berrios had 120+ additional innings of work over that same timeframe. Much of Suarez’s ultimate price tag will surely depend on how he finishes the 2024 campaign; the lefty currently leads all of MLB with an incredible 1.75 ERA through 15 starts this year and figures to find himself in the thick of the Cy Young conversation at year’s end if he can keep anything close to this production up over a full year.

Dodgers Notes: Kershaw, May, Graterol

By | at

Longtime Dodgers ace Clayton Kershaw has been sidelined for the entirety of the 2024 season to this point after undergoing shoulder surgery over the offseason, but recently began a rehab assignment as he eyes a potential return sometime next month. That rehab assignment has already hit a snag, however, as manager Dave Roberts told reporters (including Bill Plunkett of the Orange County Register) today that the veteran southpaw has felt “a little bit of soreness” in the aftermath of his rehab start for the club’s High-A affiliate in Rancho Cucamonga earlier this week.

That soreness continued today for the veteran lefty when he threw a light bullpen session, and Roberts indicated that the club is considering pushing back his next rehab start- which is currently scheduled for Tuesday- depending on how he feels in the coming days. Kershaw is expected to play catch tomorrow, and how he feels after that session could determine whether or not the Dodgers go ahead with the planned outing. The potential setback is a frustrating one, as a relatively speedy return by Kershaw would be hugely impactful for a rotation that recently lost both Yoshinobu Yamamoto and Walker Buehler to the injured list.

Those injuries left the Dodgers to turn to rookie right-hander Landon Knack in the fifth starter role behind Tyler Glasnow, Bobby Miller, Gavin Stone, and James Paxton. Outside of that group of five, however, the club is lacking in starting depth meaning further injuries could prove problematic for the club. Even setting aside L.A.’s quickly evaporating rotation depth, it’s worth noting that the 36-year-old lefty is almost assuredly one of the club’s five best starters to begin with; after all, the future Hall of Famer hasn’t posted an ERA north of 3.55 since his rookie campaign back in 2008 and managed to put together a 2.46 ERA across 24 starts last year despite playing through shoulder issues.

Roberts also provided more positive injury updates to reporters (including Jack Harris of the Los Angeles Times) this evening regarding right-handers Dustin May and Brusdar Graterol. The manager indicated that both pitchers have begun to throw bullpen sessions and called the sessions “promising.” While the timelines for each player’s return are still unclear, Roberts expressed confidence that both would return to action before the 2024 season comes to a close.

May, 26, has had a frustrating MLB career to this point. The righty debuted late in his age-21 season back in 2019 and enjoyed some success over his first two big league campaigns, with a 2.98 ERA and 3.96 FIP in 90 2/3 innings of work, first out of the bullpen in 2019 and then as a member of the rotation during the shortened 2020 campaign. May went on to win the World Series with L.A. during the pandemic-shortened campaign while pitching out of the bullpen during the postseason but returned to the rotation in 2021.

Unfortunately, he made it just five starts into the 2021 campaign before undergoing Tommy John surgery and has not put together a wire-to-wire big league season since. While the right-hander has pitched to an impressive 3.21 ERA and 3.59 FIP since the start of the 2021 campaign, he’s also been limited to just 101 innings across 20 starts during that time by the aforementioned Tommy John and a flexor tendon procedure he underwent in last July. It’s not clear whether the Dodgers hope to return May to the rotation upon his return to action or if he’ll be ticketed for the bullpen, but if healthy he figures to be an impactful arm for the club in whatever role he takes on.

As for Graterol, the 25-year-old hurler has been one of the club’s most reliable relievers since he was acquired from the Twins prior to the 2020 season. In 173 2/3 innings of work for the club since then, Graterol has pitched to an exceptional 2.69 ERA with a 3.24 FIP. He’s struck out just 18.9% of batters faced during that time but has generated an extraordinary 62.5% groundball rate as a Dodger while limiting free passes to just a 5.5% rate. Graterol figured to once again factor into the club’s high-leverage plans at the back of the bullpen this year until those plans were scuttled by a shoulder injury during Spring Training that eventually led the club to shut the righty down in late April. Should he return before the end of the season, he’d likely return to the back of the club’s bullpen alongside closer Evan Phillips.

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top